Horizon 3

Cardiac Dimensions, Inc. is a medical device company focused on developing minimally invasive treatments for heart failure and associated cardiovascular conditions. The company is known for its Carillon Mitral Contour System, a permanent implant designed to treat functional mitral regurgitation through a non-surgical, catheter-based approach that reshapes the mitral valve and reduces regurgitation. Established in 2000, Cardiac Dimensions is headquartered in Kirkland, Washington, with additional operations in Sydney, Australia, and Offenbach, Germany.

ChainCraft is a developer of mixed culture fermentation technologies that aim to produce sustainable bio-based chemicals for the chemical, food, and feed industries. The company focuses on waste mitigation by processing low-grade organic residues, such as food waste and agricultural byproducts, to create high-value fatty acids. By converting biobased organic waste streams into valuable chemical building blocks, ChainCraft offers a solution that enables industries to compete with traditional chemical production methods while promoting environmental sustainability.

ChainCraft is a developer of mixed culture fermentation technologies that aim to produce sustainable bio-based chemicals for the chemical, food, and feed industries. The company focuses on waste mitigation by processing low-grade organic residues, such as food waste and agricultural byproducts, to create high-value fatty acids. By converting biobased organic waste streams into valuable chemical building blocks, ChainCraft offers a solution that enables industries to compete with traditional chemical production methods while promoting environmental sustainability.